Within every industry, there's an Apple or a GE, says Luke Timmerman at Xconomy — "anchors" or "models of success" that other companies in that industry look up to. In biotech, that role has been filled by companies like Genentech and Genzyme, Timmerman adds, but because of buyouts and mergers in almost every regional cluster, the industry is losing its anchors.